Skip to main content

Advertisement

Log in

The percutaneous treatment of Patent Foramen Ovale, an effective and safe therapeutic choice

  • Research Article
  • Published:
Central European Journal of Medicine

Abstract

Introduction

The aim of our study is to evaluate the feasibility, safety and efficacy of the percutaneous closure of PFO (abnormal communication between the right and left atrium).

Methods

Between July 2009 and October 2012 percutaneous closure was performed in 37 patients. The presence of PFO was diagnosed through the use of ultrasound techniques: transcranial doppler with contrast (cTCD), transthoracic echocardiography(TTE) and transesophageal echocardiography (TEE). Follow-up was composed consisted of a Holter ECG 7 days after the closure with a 24 hour heart rhythm monitoring, to evaluate eventual arrhythmia cases and programmed controls which included a TTE at 1–3 months, TTE+ cTCD at 6–12 months, to evaluate the right positioning of the device and the complete closure of the defect.

Results

We obtained 100% of procedural success (correct and stable implantation of the device in a perfect position on the interatrial septum).No complications were recorded during the procedure and no new onset atrial fibrillation was detected in any patients after the PFO closure. The follow up with cTCD and TEE reported a closing rate of 86.7%. No new clinical cerebrovascular events occurred in treated patients until now.

Conclusion

Our experience describes the percutaneous PFO procedure as feasible, safe and effective with a high rate of procedural success, with an absence of significant adverse events and a high rate of complete closure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schrader R. Indication and techniques of transcatheter closure of patent foramen ovale. J Interven Cardiol. 2003; 16:543–551

    Article  Google Scholar 

  2. Homma S, Di Tullio MR, Patent foramen ovale and stroke. J Cardiol. 2010; 56:134–141

    Article  PubMed  Google Scholar 

  3. Overell JR, Bone I, and Lees KR, Interatrial septal abnormalities and stroke: A meta-analysis of casecontrol studies. Neurology. 2000; 55:1172–1179

    Article  PubMed  CAS  Google Scholar 

  4. Fazio G, Ferro G, Barbaro G, Ferrara F, Novo G, Novo S. Patent foramen ovale and thromboembolic complications. Curr Pharm Des. 2010; 16:3497–3502

    Article  PubMed  CAS  Google Scholar 

  5. Billinger M, Zbinden R, Mordasini R et al. Patent foramen ovale closure in recreational divers: effect on decompression illness and ischaemic brain lesions during long-term follow-up. Heart. 2011; 97:1932–1937

    Article  PubMed  Google Scholar 

  6. Reul J, Weis J, Jung A, Willmes K, Thron A. Central nervous system lesions and cervical disc herniations in amateur divers. Lancet. 1995; 345:1403–1405

    Article  PubMed  CAS  Google Scholar 

  7. Knauth M, Ries S, Pohimann S, et al. Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale. British medical journal. 1997; 314: 701–705

    Article  PubMed  CAS  Google Scholar 

  8. Wilmshurst P, FRCP; Nightingale S, FRCP, The Role of Cardiac and Pulmonary Pathology in Migraine: A Hypothesis. Headache. 2006; 46:429–434

    Article  PubMed  Google Scholar 

  9. Cabanes, L. et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic ictus in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke. 1993; 24:1865–1873

    Article  PubMed  CAS  Google Scholar 

  10. Lechat, P. et al. Prevalence of patent foramen ovale in patients with ictus. N. Engl. J. Med. 1998; 318: 1148–1152

    Article  Google Scholar 

  11. Webster, M. W. et al. Patent foramen ovale in young ictus patients. Lancet. 1988; 2:11–12

    Article  PubMed  CAS  Google Scholar 

  12. Job FP, Ringelstein EB, Grafen Y. Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young ictus patients. Am. J. Cardiol. 1994; 74:381–384

    Article  PubMed  CAS  Google Scholar 

  13. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic ictus. Ann. Intern. Med. 1992; 117:461–465

    Article  PubMed  Google Scholar 

  14. Yeung M, Khan KA, Shuaib A. Transcranial Doppler ultrasonography in the detection of venous to arterial shunting in acute ictus and transient ischaemic attacks. J. Neurol. Neurosurg. Psychiatry. 1996; 61:445–449

    Article  PubMed  CAS  Google Scholar 

  15. Handke M, Harloff A, Olschewski M, Hetzel A. Geibel A. Patent foramen ovale and cryptogenic ictus in older patients. N. Engl. J. Med. 2007; 357:2262–2268

    Article  PubMed  CAS  Google Scholar 

  16. Windecker S, Meier B. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else! Circulation. 2008; 118:1989–1998

    Article  PubMed  Google Scholar 

  17. Messé SR, Kasner SE. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close. Circulation. 2008;118: 1999–2004

    Article  PubMed  Google Scholar 

  18. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006; 37:577–617

    Article  PubMed  Google Scholar 

  19. O’Gara PT, Messe SR, Tuzcu EM, Catha G, Ring JC. A Call for Completion of Randomized Clinical Trials A Science Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke. AHA/ASA/Am. Coll. Circulation. 2009; 119:2743–2747

    Article  Google Scholar 

  20. Heinisch C, Bertog S, Wunderlich N et al. Percutaneous closure of the patent foramen ovale using the HELEX® Septal Occluder: acute and long-term results in 405 patients. EuroIntervention. 2012; 8:717–723

    Article  PubMed  Google Scholar 

  21. Khairy P, O’Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med. 2003; 139:753–760

    Article  PubMed  Google Scholar 

  22. Windecker S, Wahl A, Nedeltchev K, Arnold M et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic ictus. J Am Coll Cardiol. 2004; 44:750–758

    Article  PubMed  Google Scholar 

  23. Windecker, S. et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J. Am. Coll. Cardiol. 2004; 44:750–758

    Article  PubMed  Google Scholar 

  24. Furlan, A J et al. Study design of the CLOSURE I trial. A prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the Starflex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Stroke. 2010; 41:2872–2883

    Article  PubMed  Google Scholar 

  25. Patrick A. Calvert, Bushra S. Rana, Anna C. Kydd & Leonard M. Shapiro. Patent foramen ovale: anatomy, outcomes, and closure. Nat Rev Cardiol. 2011; 8:148–160

    Article  PubMed  Google Scholar 

  26. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. NEngl J Med. 2001; 345:1740–1746

    Article  CAS  Google Scholar 

  27. Fazio G, Ferro G, Carità P, Lunetta M, Gullotti A, Trapani R, Fabbiano A, Novo G, Novo S. The PFO anatomy evaluation as possible tool to stratify the associated risks and the benefits arising from the closure. European Journal of Echocardiography. 2010; 11:488–491

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. L. Trovato.

About this article

Cite this article

Evola, S., Trovato, R.L., Kauroo, B.A.W. et al. The percutaneous treatment of Patent Foramen Ovale, an effective and safe therapeutic choice. cent.eur.j.med 8, 638–643 (2013). https://doi.org/10.2478/s11536-013-0209-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-013-0209-y

Keywords

Navigation